Dunlop A. Sinclair

Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$2.2M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
APLS	Apellis Pharmaceuticals, Inc.	$0	$2.2M	-$2.2M	0	May 14

APLS

Apellis Pharmaceuticals, Inc.

-$2.2M

Bought

Sold

$2.2M

Held

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

1 of 3 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 75 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Jun 24, 2025	Oct 14, 2025	APLSApellis Pharmaceuticals, Inc.	75days · about 4 months	$737.5K	Filing ↗

APLS

Apellis Pharmaceuticals, Inc.

75days · about 4 months

Traded Jun 24, 2025 · filed Oct 14, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.

Trade history

The 21 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
May 14	APLS	Apellis Pharmaceuticals,…	DTOISS◆	5,748	—	—	—	Open the original filing on SEC.gov
May 14	APLS	Apellis Pharmaceuticals,…	DTOISS◆	27,600	—	—	—